Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study
NCT03057158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257
Last updated 2020-09-29
Summary
Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women get overactive bladder in the first place so that better treatments can eventually be offered.
The purpose of this study is to determine why women with insulin resistance are more likely to get overactive bladder. Overactive bladder is a type of bladder control problem that can cause some women to have bladder leakage. This problem is more common in women with diabetes and pre-diabetes, but it isn't known why.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Nazema Y Siddiqui, MD · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-01
- Primary Completion
- 2020-03-09
- Completion
- 2020-03-11
Countries
- United States
Study Locations
More Related Trials
-
The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.
NCT06111508 ·Status: COMPLETED ·Phase: NA
-
Estimate Rate of the Women Who Have Gestational Diabetes
NCT02852980 ·Status: COMPLETED
-
Metabolic Risk and Life Style Factors in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT03050645 ·Status: COMPLETED
-
OneinSeven Gestational Diabetes Genetic and Socioeconomic Risk Study
NCT04789473 ·Status: UNKNOWN
-
Continuous Glucose Monitoring in Patients With Type 2 Diabetes
NCT00529815 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of Gestational Diabetes Mellitus Related Urinary Biomarkers Along Pregnancy (From Early Pregnancy to Postpartum) by Using Proteomics and Metabolomics Analysis
NCT03246295 ·Status: UNKNOWN
-
Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women With or Without a High Risk for GDM
NCT05537480 ·Status: UNKNOWN ·Phase: NA
-
Intensive Management for Gestational Diabetes
NCT02530866 ·Status: COMPLETED ·Phase: NA
-
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NCT06570278 ·Status: RECRUITING ·Phase: NA
-
Continuous Glucose Monitoring and Hypoglycemia Unawareness in Type 1 Diabetes
NCT03605979 ·Status: COMPLETED
-
Genetic and Epigenetic Mechanisms of Developing Gestational Diabetes Mellitus and Its Effects on the Fetus
NCT03610178 ·Status: COMPLETED ·Phase: NA
-
Insulin Action During Pregnancy in Woman at High Risk for Gestational Diabetes
NCT00687479 ·Status: COMPLETED
-
Predictability of Gestational Diabetes Mellitus in First and Second Trimester
NCT02035059 ·Status: COMPLETED
-
Early Screening for Gestational Diabetes Mellitus
NCT01026675 ·Status: COMPLETED
-
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
NCT01788527 ·Status: COMPLETED ·Phase: NA
-
Technological Advances in Glucose Management in Older Adults
NCT03078491 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
NCT00835861 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers for Early Screening of Gestational Diabetes Mellitus
NCT05142020 ·Status: UNKNOWN
-
Study on Glycemic Variations in Diabetic Patients Treated With Chemotherapy: Benefit of Continuous Interstitial Glucose Measurement
NCT04315857 ·Status: COMPLETED
-
Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)
NCT04473430 ·Status: COMPLETED ·Phase: NA
-
Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
NCT03029702 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Glucose Monitor Use in Pregnancy
NCT05317585 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women
NCT01756105 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
NCT05741489 ·Status: COMPLETED ·Phase: NA